₨ 18,000
Velpaget is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is a fixed-dose combination tablet containing sofosbuvir (400mg) and velpatasvir (100mg).
Key Information
- Active Ingredients: Sofosbuvir and Velpatasvir.
- Manufacturer: Getz Pharma.
- Form: Tablets.
- Indication: Treatment of chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6, both with or without compensated cirrhosis. For patients with decompensated cirrhosis, it is used in combination with ribavirin.
Potential Side Effects and Warnings
Common side effects can include headache, fatigue, nausea, and diarrhea.Important Warnings:
- Hepatitis B Reactivation: Patients should be tested for current or prior hepatitis B virus (HBV) infection before starting treatment. HBV can become active again during or after treatment with this medication, potentially causing serious liver problems.
- Heart Issues: Use with heart rhythm medication amiodarone can cause serious, life-threatening side effects, including a very slow heart rate or cardiac arrest.
Disclaimer: This information is for informational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider for any medical conditions or before starting any new treatment.
₨ 10,000
